ALPHARETTA, Ga., March 08, 2017 -- Aptean, a leading global provider of industry-focused mission critical enterprise software solutions, has announced Fusion5, a business applications company with offices in Australia and New Zealand, as the recipient of its 2016 Partner of the Year Award. The Aptean Partner of the Year Award recognizes outstanding sales achievement and revenue attainment. 2017 marks the sixteenth year of the Fusion5 and Aptean partnership.
During Aptean’s annual Partner Conference Fusion5 was recognized as 2016 Partner of the Year. Fusion5 has found success using Aptean’s Pivotal platform to develop robust industry leading software solutions in the education management field, specifically grant management and student management.
“We’re delighted that for the second year running Aptean has recognised our achievements with Pivotal, through this award,” says Sven Martin, Fusion5 Executive Director. “Our customers are embracing digital transformation as the top strategy to fuel their growth. We empower them throughout their journey with key innovations built on the flexible and robust Pivotal platform to help continuously drive increased value.”
“Aptean is pleased to recognize Fusion5 and their dedicated team as Aptean’s Partner of the Year,” said Kyle Bowker, Executive Vice President of Global Account Management and Marketing. “Our partner community plays a critical role in Aptean’s global growth strategy and provides valuable insight into investments Aptean can make to further strengthen the solutions we bring to market.”
Aptean’s success is supported by the commitment of a Partner community that invests in and delivers value added solutions, customer retention and market share growth. The recipient of Aptean’s Partner of the Year Award distinguishes the Partner with the highest total revenue achievement and acknowledges their significant contribution to Aptean’s growth.
To learn more about becoming an Aptean Partner, contact us at [email protected].
ABOUT FUSION5
Fusion5 is a business applications company delivering world class solutions across key functional areas of an organization, including Enterprise Resource Planning, Customer Relationship Management, Customer Experience, HR / Payroll and IT Service Management. We develop best of breed solutions across a number of key industries serving over 700 customers across Australia and New Zealand. For more information, visit www.fusion5.com.au.
ABOUT APTEAN
Aptean is a leading global provider of industry-focused mission critical enterprise software solutions. We build and acquire solutions to support the evolving operational needs of our customers. Our solutions help nearly 6,500 organizations stay at the forefront of their industries by enabling them to operate more efficiently, thereby ensuring higher customer satisfaction. For more information, visit www.aptean.com.
Aptean is a trademark of Aptean, Inc. All other company and product names may be trademarks of the respective companies with which they are associated.
FOR MORE INFORMATION Media Relations Melissa Floyd, Aptean [email protected]


Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



